We are live on ! Find out more
TECX

Tectonic Therapeutic

70 hedge funds and large institutions have $355M invested in Tectonic Therapeutic in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

213% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 8

63% more capital invested

Capital invested by funds: $217M → $355M (+$137M)

40% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 15

32% more funds holding

Funds holding: 5370 (+17)

3.4% more ownership

Funds ownership: 48.72%52.11% (+3.4%)

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
70
Holders Change
+17
Holders Change %
+32.08%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
25
Increased
21
Reduced
15
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
-$5K -155 Closed
DB
77
Danske Bank
Denmark
-$61 -2 Closed
Group One Trading
78
Group One Trading
Illinois
-$30 -1 Closed

TECX Hedge Fund Activity: Q4 2024 in Review

70 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q4 2024, worth a combined $355M — up 63% from $217M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TECX positions and 8 closed out — a net gain of 17 holders — while 21 added to existing stakes and 15 trimmed.

The largest buyer was Paradigm Biocapital Advisors, opening a new position worth an estimated $20.5M. The largest seller was Atlas Venture Life Science Advisors, cutting an estimated $12.7M.

  • 70 institutional investors held Tectonic Therapeutic (TECX) as of Q4 2024, up from 53 in Q3 2024.
  • Funds reported $355M of Tectonic Therapeutic stock for Q4 2024, up 63% quarter-over-quarter.
  • 25 funds opened new Tectonic Therapeutic positions in Q4 2024 and 8 closed out, a net change of +17 holders.
  • The largest Tectonic Therapeutic buyer in Q4 2024 was Paradigm Biocapital Advisors, an estimated $20.5M added.
  • The largest Tectonic Therapeutic seller in Q4 2024 was Atlas Venture Life Science Advisors, an estimated $12.7M sold.

Based on aggregated 13F filings for Q4 2024.